29 related articles for article (PubMed ID: 24398385)
1. Fucoidan--a α-D-glucosidase inhibitor from Sargassum wightii with relevance to type 2 diabetes mellitus therapy.
Vinoth Kumar T; Lakshmanasenthil S; Geetharamani D; Marudhupandi T; Suja G; Suganya P
Int J Biol Macromol; 2015 Jan; 72():1044-7. PubMed ID: 25453283
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3-hydroxy-2-naphthohydrazide-based hydrazones and their implications in diabetic management via in vitro and in silico approaches.
Tasleem M; Ullah S; Halim SA; Urooj I; Ahmed N; Munir R; Khan A; El-Kott AF; Taslimi P; Negm S; Al-Harrasi A; Shafiq Z
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300544. PubMed ID: 38013251
[TBL] [Abstract][Full Text] [Related]
3. Arene-Ruthenium(II) Complexes Containing 11
Matveevskaya VV; Pavlov DI; Sukhikh TS; Gushchin AL; Ivanov AY; Tennikova TB; Sharoyko VV; Baykov SV; Benassi E; Potapov AS
ACS Omega; 2020 May; 5(19):11167-11179. PubMed ID: 32455240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activities, and evaluation molecular docking-dynamics studies of new phenylisoxazole quinoxalin-2-amine hybrids as potential α-amylase and α-glucosidase inhibitors.
Mohd Radzuan SN; Phongphane L; Abu Bakar MH; Che Omar MT; Nor Shahril NS; Supratman U; Harneti D; Wahab HA; Azmi MN
RSC Adv; 2024 Feb; 14(11):7684-7698. PubMed ID: 38444963
[TBL] [Abstract][Full Text] [Related]
5. New multicomponent reactions in water: a facile synthesis of 1,3-dioxo-2-indanilidene-heterocyclic scaffolds and indenoquinoxalines through reaction of ninhydrin-malononitrile adduct with diverse
Rahimi Z; Bayat M; Hosseini H
RSC Adv; 2022 Nov; 12(52):33772-33779. PubMed ID: 36505672
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic compounds as a magic bullet for diabetes mellitus: a review.
Farwa U; Raza MA
RSC Adv; 2022 Aug; 12(35):22951-22973. PubMed ID: 36105949
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors.
Pedrood K; Rezaei Z; Khavaninzadeh K; Larijani B; Iraji A; Hosseini S; Mojtabavi S; Dianatpour M; Rastegar H; Faramarzi MA; Hamedifar H; Hajimiri MH; Mahdavi M
BMC Chem; 2022 Jul; 16(1):57. PubMed ID: 35909126
[TBL] [Abstract][Full Text] [Related]
8. Green Synthesis of Indeno[1,2-b]quinoxalines Using β-Cyclodextrin as Catalyst.
Liao LG; Song MM; Feng JF; Tan M; Liu F; Qiu ZJ; Zhang S; Li BJ
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056894
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor.
Schepetkin IA; Kirpotina LN; Hammaker D; Kochetkova I; Khlebnikov AI; Lyakhov SA; Firestein GS; Quinn MT
J Pharmacol Exp Ther; 2015 Jun; 353(3):505-16. PubMed ID: 25784649
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents.
Mohan S; Eskandari R; Pinto BM
Acc Chem Res; 2014 Jan; 47(1):211-25. PubMed ID: 23964564
[TBL] [Abstract][Full Text] [Related]
11. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Sakamoto N; Tajima N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
[No Abstract] [Full Text] [Related]
12. Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitors.
Khan MS; Munawar MA; Ashraf M; Alam U; Ata A; Asiri AM; Kousar S; Khan MA
Bioorg Med Chem; 2014 Feb; 22(3):1195-200. PubMed ID: 24398385
[TBL] [Abstract][Full Text] [Related]
13. Potent α-glucosidase and protein tyrosine phosphatase 1B inhibitors from Artemisia capillaris.
Nurul Islam M; Jung HA; Sohn HS; Kim HM; Choi JS
Arch Pharm Res; 2013 May; 36(5):542-52. PubMed ID: 23435948
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel oxindole derivatives as potent α-glucosidase inhibitors.
Khan M; Yousaf M; Wadood A; Junaid M; Ashraf M; Alam U; Ali M; Arshad M; Hussain Z; Khan KM
Bioorg Med Chem; 2014 Jul; 22(13):3441-8. PubMed ID: 24825482
[TBL] [Abstract][Full Text] [Related]
15. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
